Danielle Botta‐Fridlund

2.5k total citations
48 papers, 1.5k citations indexed

About

Danielle Botta‐Fridlund is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Danielle Botta‐Fridlund has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hepatology, 31 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Danielle Botta‐Fridlund's work include Liver Disease Diagnosis and Treatment (24 papers), Hepatitis C virus research (20 papers) and Liver Disease and Transplantation (18 papers). Danielle Botta‐Fridlund is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Hepatitis C virus research (20 papers) and Liver Disease and Transplantation (18 papers). Danielle Botta‐Fridlund collaborates with scholars based in France, United States and Switzerland. Danielle Botta‐Fridlund's co-authors include Marc Bourlière, Philippe Halfon, Isabelle Portal, Denis Ouzan, Albert Tran, Didier Samuel, Christophe Renou, Guillaume Pénaranda, R. Deydier and René Gerolami and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Journal of Clinical Microbiology.

In The Last Decade

Danielle Botta‐Fridlund

48 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle Botta‐Fridlund France 20 1.3k 1.1k 268 72 50 48 1.5k
G. Bellati Italy 23 1.2k 0.9× 1.0k 0.9× 271 1.0× 64 0.9× 58 1.2× 49 1.4k
Vincents J. Dindzans United States 14 595 0.5× 480 0.4× 302 1.1× 41 0.6× 29 0.6× 31 870
Leonardo de Lucca Schiavon Brazil 19 753 0.6× 825 0.7× 175 0.7× 63 0.9× 10 0.2× 99 1.2k
Helena Allende Spain 22 1.0k 0.8× 970 0.8× 285 1.1× 76 1.1× 43 0.9× 60 1.4k
Nobuaki Nakayama Japan 18 925 0.7× 775 0.7× 256 1.0× 94 1.3× 18 0.4× 72 1.2k
Piotr Czubkowski Poland 15 361 0.3× 337 0.3× 385 1.4× 43 0.6× 49 1.0× 62 781
Galip Ersöz Türkiye 19 536 0.4× 689 0.6× 524 2.0× 78 1.1× 9 0.2× 82 1.3k
Nancy Bach United States 17 1.3k 1.1× 1.2k 1.0× 402 1.5× 30 0.4× 6 0.1× 33 1.6k
Kazuhiko Sekiyama Japan 15 680 0.5× 527 0.5× 198 0.7× 77 1.1× 24 0.5× 27 913
A. Picciotto Italy 20 533 0.4× 543 0.5× 90 0.3× 52 0.7× 9 0.2× 85 968

Countries citing papers authored by Danielle Botta‐Fridlund

Since Specialization
Citations

This map shows the geographic impact of Danielle Botta‐Fridlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Botta‐Fridlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Botta‐Fridlund more than expected).

Fields of papers citing papers by Danielle Botta‐Fridlund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Botta‐Fridlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Botta‐Fridlund. The network helps show where Danielle Botta‐Fridlund may publish in the future.

Co-authorship network of co-authors of Danielle Botta‐Fridlund

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Botta‐Fridlund. A scholar is included among the top collaborators of Danielle Botta‐Fridlund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Botta‐Fridlund. Danielle Botta‐Fridlund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borentain, Patrick, Noémie Resseguier, Danielle Botta‐Fridlund, et al.. (2016). The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement. Diagnostic and Interventional Imaging. 97(6). 643–650. 22 indexed citations
2.
Borentain, Patrick, Stéphane Garcia, Émilie Grégoire, et al.. (2014). Transjugular intrahepatic porto-systemic shunt is a risk factor for liver dysplasia but not hepatocellular carcinoma: A retrospective study of explanted livers. Digestive and Liver Disease. 47(1). 57–61. 11 indexed citations
3.
Coilly, Audrey, Bruno Roche, Jérôme Dumortier, et al.. (2013). Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience. Journal of Hepatology. 60(1). 78–86. 142 indexed citations
4.
Barbier, Louise, Stéphane Garcia, Jérôme Cros, et al.. (2013). Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors. Journal of Hepatology. 59(6). 1223–1230. 21 indexed citations
5.
Barbier, Louise, Jean Hardwigsen, Patrick Borentain, et al.. (2013). Impact of transjugular intrahepatic portosystemic shunting on liver transplantation: 12-year single-center experience. Clinics and Research in Hepatology and Gastroenterology. 38(2). 155–163. 19 indexed citations
6.
Romanet, Pauline, Henri Vacher-Coponat, Valérie Moal, et al.. (2011). Pitfall of hepatitis B surface antigen testing in a kidney transplant recipient presenting hepatitis B reactivation. Clinics and Research in Hepatology and Gastroenterology. 35(10). 671–674. 2 indexed citations
7.
Gaubert, Jean‐Yves, et al.. (2009). Functional improvement in a patient with cirrhosis and portopulmonary hypertension treated by sildenafil for 2 years. Respiratory Medicine CME. 3(4). 263–266. 1 indexed citations
8.
Colson, Philippe, Patrick Borentain, Anne Motte, et al.. (2007). Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers. Virology. 367(1). 30–40. 61 indexed citations
9.
Borentain, Patrick, Philippe Grandval, Pascal Ananian, et al.. (2007). Tuberculose céphalopancréatique : une cause rare d’ictère obstructif accessible à un traitement conservateur. Gastroentérologie Clinique et Biologique. 31(11). 1024–1027. 3 indexed citations
10.
Halfon, Philippe, Marc Bourlière, R. Deydier, et al.. (2006). Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest-Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study. The American Journal of Gastroenterology. 101(3). 547–555. 119 indexed citations
11.
Bourlière, Marc, Guillaume Pénaranda, Christophe Renou, et al.. (2006). Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. Journal of Viral Hepatitis. 13(10). 659–670. 112 indexed citations
12.
Halfon, Philippe, Marc Bourlière, Guillaume Pénaranda, et al.. (2005). Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. PubMed. 4(1). 6–6. 121 indexed citations
13.
Hardwigsen, Jean, Eric Mas, Anne‐Marie Benoliel, et al.. (2004). Effect of Ischemia—Reperfusion on Na+,K+-ATPase Expression in Human Liver Tissue Allograft: Image Analysis by Confocal Laser Scanning Microscopy. Digestive Diseases and Sciences. 49(9). 1387–1393. 10 indexed citations
14.
Leroy, Vincent, Marc Bourlière, Albert Tran, et al.. (2002). The antibody response to hepatitis B virus vaccination is negatively influenced by the hepatitis C virus viral load in patients with chronic hepatitis C: a case–control study. European Journal of Gastroenterology & Hepatology. 14(5). 485–489. 34 indexed citations
15.
Castellani, Patrizia, G. Moulin, Jean‐Michel Bartoli, et al.. (2001). Is transjugular intrahepatic portosystemic shunt really deleterious for liver transplantation issue? a monocentric study on 86 liver transplanted patients. Transplantation Proceedings. 33(7-8). 3468–3469. 12 indexed citations
16.
Hardwigsen, Jean, et al.. (2001). Effect of Ischemia–Reperfusion on Bile Canalicular F-Actin Microfilaments in Hepatocytes of Human Liver Allograft. Digestive Diseases and Sciences. 46(8). 1663–1667. 24 indexed citations
17.
Bourlière, Marc, Marguerite Gastaldi, Paul Castellani, et al.. (2000). Absence of hepatitis C genome in semen of infected men by polymerase chain reaction, branched DNA and in situ hybridization. Liver International. 20(3). 257–261. 37 indexed citations
18.
Hardwigsen, Jean, et al.. (1999). Effect of ischemia-reperfusion on the heterogeneous lobular distribution pattern of glycogen content and glucose-6-phosphatase activity in human liver allograft.. PubMed. 45(8). 1209–15. 5 indexed citations
19.
Delescluse, C., et al.. (1997). Comparative study of CYP1A1 induction by 3-methylcholanthrene in various human hepatic and epidermal cell types. Toxicology in Vitro. 11(5). 443–450. 32 indexed citations
20.
Sbarra, Véronique, et al.. (1994). Bile salt secretion by hepatocytes incubated with bile salts and liposomes or low density lipoproteins. Life Sciences. 56(4). 277–286. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Bellati Breakdown of academic impact, for papers by Vincents J. Dindzans Breakdown of academic impact, for papers by Leonardo de Lucca Schiavon Breakdown of academic impact, for papers by Helena Allende Breakdown of academic impact, for papers by Nobuaki Nakayama Breakdown of academic impact, for papers by Piotr Czubkowski Breakdown of academic impact, for papers by Galip Ersöz Breakdown of academic impact, for papers by Nancy Bach Breakdown of academic impact, for papers by Kazuhiko Sekiyama Breakdown of academic impact, for papers by A. Picciotto
Rankless by CCL
2026